Back to Results
First PageMeta Content



XOFLUZATM (Baloxavir Marboxil) Tablets 10mg/20mg Approved for the Treatment of Influenza Types A and B in Japan Osaka, Japan, February 23, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi,
Add to Reading List

Document Date: 2018-02-25 01:50:36


Open Document

File Size: 81,08 KB

Share Result on Facebook